D.E. Shaw & Co
DMAA

D.E. Shaw & Co’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

D.E. Shaw & Co’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-690,000
Closed -$7.25M – 5324
2026
Q1 		$7.25M Hold
690,000
– – ﹤0.01% 1885
2025
Q4 		$7.16M Hold
690,000
– – ﹤0.01% 2036
2025
Q3 		$7.09M Hold
690,000
– – ﹤0.01% 1931
2025
Q2 		$7.04M Buy
+690,000
New +$6.98M 0.01% 1764

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.69% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.69% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.5% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.76B AUM 23.76% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

D.E. Shaw & Co's DMAA Position: Q2 2026 in Review

D.E. Shaw & Co sold out of Drugs Made In America Acquisition Corp (DMAA) in Q2 2026, closing a stake of 690,000 shares — an estimated $7.25M sold.

D.E. Shaw & Co first reported a position in DMAA in Q2 2025 and held it in 4 quarters. The position peaked at $7.25M in Q1 2026. 18 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

  • D.E. Shaw & Co reported no remaining Drugs Made In America Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 690,000 Drugs Made In America Acquisition Corp shares in Q2 2026, an estimated $7.25M.
  • D.E. Shaw & Co first reported a position in Drugs Made In America Acquisition Corp in Q2 2025 and held it in 4 quarters.
  • D.E. Shaw & Co's Drugs Made In America Acquisition Corp position peaked at $7.25M in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.